IGMS IGM Biosciences Inc

Price (delayed)

$14.11

Market cap

$823.94M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.97

Enterprise value

$689.72M

Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. Since 2010, IGM Biosciences has worked to overcome the manufacturing ...

Highlights
IGMS's revenue has surged by 166% year-on-year and by 11% since the previous quarter
IGM Biosciences's gross profit has surged by 166% YoY and by 11% QoQ
IGM Biosciences's quick ratio has decreased by 15% YoY but it has increased by 3.1% QoQ
IGM Biosciences's debt has increased by 47% YoY
IGM Biosciences's equity has decreased by 23% YoY

Key stats

What are the main financial stats of IGMS
Market
Shares outstanding
58.39M
Market cap
$823.94M
Enterprise value
$689.72M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.24
Price to sales (P/S)
454.18
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
372.62
Earnings
Revenue
$1.85M
EBIT
-$237.86M
EBITDA
-$224.51M
Free cash flow
-$195.71M
Per share
EPS
-$4.97
Free cash flow per share
-$3.28
Book value per share
$4.35
Revenue per share
$0.03
TBVPS
$7.96
Balance sheet
Total assets
$474.35M
Total liabilities
$220.49M
Debt
$41.19M
Equity
$253.86M
Working capital
$355.43M
Liquidity
Debt to equity
0.16
Current ratio
9.27
Quick ratio
9.02
Net debt/EBITDA
0.6
Margins
EBITDA margin
-12,129%
Gross margin
100%
Net margin
-12,874%
Operating margin
-13,755.1%
Efficiency
Return on assets
-49.4%
Return on equity
-91.7%
Return on invested capital
-71.5%
Return on capital employed
-55.1%
Return on sales
-12,850.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IGMS stock price

How has the IGM Biosciences stock price performed over time
Intraday
9.04%
1 week
-18.72%
1 month
32.74%
1 year
-33.54%
YTD
69.8%
QTD
69.8%

Financial performance

How have IGM Biosciences's revenue and profit performed over time
Revenue
$1.85M
Gross profit
$1.85M
Operating income
-$254.61M
Net income
-$238.3M
Gross margin
100%
Net margin
-12,874%
IGMS's revenue has surged by 166% year-on-year and by 11% since the previous quarter
IGM Biosciences's gross profit has surged by 166% YoY and by 11% QoQ
IGM Biosciences's net margin has soared by 59% YoY and by 8% from the previous quarter
IGMS's operating margin has surged by 57% year-on-year and by 7% since the previous quarter

Growth

What is IGM Biosciences's growth rate over time

Valuation

What is IGM Biosciences stock price valuation
P/E
N/A
P/B
3.24
P/S
454.18
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
372.62
The EPS is up by 13% year-on-year and by 5% since the previous quarter
The stock's P/B is 43% below its 5-year quarterly average of 5.2 but 42% above its last 4 quarters average of 2.1
IGM Biosciences's equity has decreased by 23% YoY
IGMS's revenue has surged by 166% year-on-year and by 11% since the previous quarter
IGMS's price to sales (P/S) is 7% more than its last 4 quarters average of 390.7

Efficiency

How efficient is IGM Biosciences business performance
The return on sales has surged by 59% year-on-year and by 8% since the previous quarter
IGMS's return on equity is down by 21% year-on-year and by 9% since the previous quarter
The return on invested capital rose by 14% year-on-year but it has declined by 5% since the previous quarter
The ROA has grown by 5% YoY but it has contracted by 5% from the previous quarter

Dividends

What is IGMS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IGMS.

Financial health

How did IGM Biosciences financials performed over time
The total assets is 115% greater than the total liabilities
IGM Biosciences's quick ratio has decreased by 15% YoY but it has increased by 3.1% QoQ
IGM Biosciences's current ratio has decreased by 14% YoY but it has increased by 2.2% QoQ
IGM Biosciences's debt is 84% less than its equity
IGMS's debt to equity has soared by 78% YoY
IGM Biosciences's debt has increased by 47% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.